Drugs / capromorelin
last change Jan 2009 re-read 3 minutes ago

capromorelin

Small molecule targets GHSR via activation

Investigated by
Pfizer

Trials 1

2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00527046 Dec 1999 → Oct 2001 — Pfizer Terminated No outcome recorded

Evidence & citations 13 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as capromorelin “the orally active GHS capromorelin in older adults with mild functional limitation” PMID 19174493 ↗ Jan 2009
Known as Capimorelin ChEMBL registry synonym — accepted as the source's own label CHEMBL113313 ↗
Known as Capimorelin tartrate ChEMBL registry synonym — accepted as the source's own label CHEMBL113313 ↗
Known as CAPROMORELIN TARTRATE ChEMBL registry synonym — accepted as the source's own label CHEMBL113313 ↗
Known as Capromorelina ChEMBL registry synonym — accepted as the source's own label CHEMBL113313 ↗
Known as Capromoreline ChEMBL registry synonym — accepted as the source's own label CHEMBL113313 ↗
Known as CP-424,391 ChEMBL registry synonym — accepted as the source's own label CHEMBL113313 ↗
Known as CP-424,391-18 ChEMBL registry synonym — accepted as the source's own label CHEMBL113313 ↗
Known as Eluracat ChEMBL registry synonym — accepted as the source's own label CHEMBL113313 ↗
Action Activate “Ghrelin receptor agonist” CHEMBL113313 ↗
Modality Small molecule — CHEMBL113313 ↗
Route Oral “the orally active GHS capromorelin” PMID 19174493 ↗ Jan 2009
Target GHSR “Ghrelin receptor agonist” CHEMBL113313 ↗